United Asset Strategies’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-112,300
Closed -$121K 164
2017
Q1
$121K Hold
112,300
0.04% 142
2016
Q4
$116K Hold
112,300
0.04% 144
2016
Q3
$117K Hold
112,300
0.04% 135
2016
Q2
$164K Buy
+112,300
New +$164K 0.06% 135